Header Logo

Connection

REYNOLDS DELGADO to Middle Aged

Back to Details
This is a "connection" page, showing publications REYNOLDS DELGADO has written about Middle Aged.
REYNOLDS DELGADO
Connection Strength
0.218
Middle Aged
  1. Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices. Gen Thorac Cardiovasc Surg. 2020 Nov; 68(11):1278-1284.
    View in: PubMed
    Score: 0.028
  2. Direct thrombolytic therapy for thrombosis of a centrifugal flow left ventricular assist device. ASAIO J. 2013 Sep-Oct; 59(5):530-2.
    View in: PubMed
    Score: 0.018
  3. Bivalirudin for treatment of aortic valve thrombosis after left ventricular assist device implantation. ASAIO J. 2013 Jul-Aug; 59(4):448-9.
    View in: PubMed
    Score: 0.017
  4. The effect of administering erythropoiesis-stimulating proteins in patients with chronic heart failure: results from a retrospective study. Congest Heart Fail. 2006 Nov-Dec; 12(6):297-301.
    View in: PubMed
    Score: 0.011
  5. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006; 33(2):111-5.
    View in: PubMed
    Score: 0.010
  6. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart. J Heart Lung Transplant. 2005 Aug; 24(8):1166-70.
    View in: PubMed
    Score: 0.010
  7. West Nile virus infection after cardiac transplantation. J Heart Lung Transplant. 2005 Jun; 24(6):774-6.
    View in: PubMed
    Score: 0.010
  8. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant. 2005 Feb; 24(2):231-3.
    View in: PubMed
    Score: 0.010
  9. Intravenous milrinone in treatment of advanced congestive heart failure. Tex Heart Inst J. 2003; 30(2):109-13.
    View in: PubMed
    Score: 0.008
  10. Ten-Year Survival With a Continuous-Flow Left Ventricular Assist Device and Aortic Valve Closure. Tex Heart Inst J. 2020 08 01; 47(4):325-328.
    View in: PubMed
    Score: 0.007
  11. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients. ASAIO J. 2020 05; 66(5):539-546.
    View in: PubMed
    Score: 0.007
  12. Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
    View in: PubMed
    Score: 0.007
  13. Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device. Ann Thorac Surg. 2020 06; 109(6):e439-e440.
    View in: PubMed
    Score: 0.007
  14. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018 Sep; 21(3):285-292.
    View in: PubMed
    Score: 0.006
  15. Adenocarcinoma of the parotid gland metastatic to the ventricular septum and right ventricular wall. Tex Heart Inst J. 2012; 39(2):258-60.
    View in: PubMed
    Score: 0.004
  16. Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction. BMC Cardiovasc Disord. 2010 Jun 16; 10:28.
    View in: PubMed
    Score: 0.004
  17. Snake heart: a case of atavism in a human being. Tex Heart Inst J. 2010; 37(6):687-90.
    View in: PubMed
    Score: 0.003
  18. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009 Dec 03; 361(23):2241-51.
    View in: PubMed
    Score: 0.003
  19. Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support. Eur J Heart Fail. 2009 Oct; 11(10):1000-4.
    View in: PubMed
    Score: 0.003
  20. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM). Circulation. 2008 Sep 16; 118(12):1241-9.
    View in: PubMed
    Score: 0.003
  21. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
    View in: PubMed
    Score: 0.003
  22. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007 Aug 30; 357(9):885-96.
    View in: PubMed
    Score: 0.003
  23. Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis. Am J Cardiol. 2007 Jun 15; 99(12):1755-6.
    View in: PubMed
    Score: 0.003
  24. Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant. 2006 Apr; 25(4):395-9.
    View in: PubMed
    Score: 0.003
  25. Myocardial perfusion as assessed by positron emission tomography during long-term mechanical circulatory support. Congest Heart Fail. 2006 Mar-Apr; 12(2):69-74.
    View in: PubMed
    Score: 0.003
  26. Peripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support. J Heart Lung Transplant. 2006 Apr; 25(4):391-4.
    View in: PubMed
    Score: 0.003
  27. Recovery from multi-organ failure in a patient with a continuous-flow left ventricular assist device. J Heart Lung Transplant. 2006 Jan; 25(1):148.
    View in: PubMed
    Score: 0.003
  28. Recovery from multi-organ failure in a patient with a continuous-flow left ventricular assist device. J Heart Lung Transplant. 2005 Aug; 24(8):1128-9.
    View in: PubMed
    Score: 0.003
  29. Antiphospholipid syndrome with anti-prothrombin autoantibodies in a patient with an axial-flow left ventricular assist device. J Heart Lung Transplant. 2005 Aug; 24(8):1133-6.
    View in: PubMed
    Score: 0.003
  30. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail. 2005 May-Jun; 11(3):133-8.
    View in: PubMed
    Score: 0.002
  31. Images in cardiovascular medicine. High left ventricular assist device flows resulting from combined native aortic valve and outflow valve regurgitation. Circulation. 2005 Feb 01; 111(4):e34.
    View in: PubMed
    Score: 0.002
  32. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005 Jan; 24(1):105-9.
    View in: PubMed
    Score: 0.002
  33. Quality of life in bridge-to-transplant patients with chronic heart failure after implantation of an axial flow ventricular assist device. Congest Heart Fail. 2004 Sep-Oct; 10(5):226-9.
    View in: PubMed
    Score: 0.002
  34. Mechanical bridging to improvement in severe acute "nonischemic, nonmyocarditis" heart failure. Congest Heart Fail. 2004 Mar-Apr; 10(2):109-13.
    View in: PubMed
    Score: 0.002
  35. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg. 2003 Oct; 76(4):1167-70.
    View in: PubMed
    Score: 0.002
  36. Orthotopic cardiac transplantation 30 months after successful dynamic cardiomyoplasty. Ann Thorac Surg. 2003 Oct; 76(4):1289-91.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.